Zacks.com on MSN
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy?
CorMedix and Theravance take sharply different routes to small-cap biotech growth - one fueled by sales traction, the other by pipeline promise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback